A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
Recruiting · NCT07222670 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age | Viral Respiratory Illnesses; Viral Respiratory Infection | Recruiting | Phase 2 | 2026-09-11 | NCT07222670 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ENA Respiratory Pty Ltd | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Accellacare - Wilmington | Wilmington | United States | 1 |
| Accellacare of Piedmont Healthcare | Statesville | United States | 7 |
| Accellacare of Raleigh | Raleigh | United States | 6 |
| Center for Vaccine Development and Global Health (CVD) | Baltimore | United States | 1 |
| Naval Medical Research Command (NMRC) | Bethesda | United States | 1 |